Joshua S. Boger

CIK: 0001197023

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRVO

CervoMed Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CRVO
CervoMed Inc.
Jun 11, 2026
Purchase(P)
Indirect
955.4K shares at avg. $3.14$3.0M
CRVO
CervoMed Inc.
Jun 8, 2026
Award(A)
Stock Option (Right to Buy)
Direct
8.2K shares-
CRVO
CervoMed Inc.
Jun 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
8.1K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	CRVO CervoMed Inc.	Purchase(P)	955,414	$3.14	$3,000,000	Indirect
Jun 8, 2026	CRVO CervoMed Inc.	Award(A) Stock Option (Right to Buy)	8,150	-	-	Direct
Jun 23, 2025	CRVO CervoMed Inc.	Award(A) Stock Option (Right to Buy)	8,100	-	-	Direct

1-3 of 3 transactions

About BOGER JOSHUA S

BOGER JOSHUA S (SEC CIK 0001197023) files insider reports with the SEC as Director of CervoMed Inc. (CRVO).

Signal8 holds 3 ownership filings by BOGER JOSHUA S, all Form 4s, filed between Jun 25, 2025 and Jun 15, 2026. Those filings report 3 transactions, from Jun 23, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BOGER JOSHUA S's filings is in BOSTON, MA.

Recent filings by BOGER JOSHUA S

Jun 11, 2026: Open-market purchase of CRVO shares (Form 4, code P).
Jun 8, 2026: Grant or award of CRVO derivative securities (Form 4, code A).
Jun 23, 2025: Grant or award of CRVO derivative securities (Form 4, code A).

Other insiders filing for CervoMed Inc. (CRVO)

Blackburn Kelly, EVP, Clinical Development
De Rosch Mark, EVP, RA and GA and PgM
Winton Matthew, Chief Commercial and Business
ZAVRL FRANK, Director
Sabbagh Marwan, Director
Quigley David, Director

How to read Form 4 transaction codes